Form 4: Allogene Therapeutics CEO David Chang Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Allogene Therapeutics CEO David Chang sold 46,003 shares of common stock on February 3, 2025, to cover tax withholding obligations related to the vesting of restricted stock units.
Summary
- On February 3, 2025, David Chang, the President and CEO of Allogene Therapeutics, sold 46,003 shares of Allogene's common stock at a weighted average price of $1.68 per share.
- The sale was executed to cover tax withholding obligations associated with the vesting of restricted stock units, as mandated by Allogene's equity incentive plan.
- Following the transaction, Chang directly owns 5,317,237 shares of Allogene's common stock.
- Chang also indirectly owns shares through several trusts: 856,044 shares via the RTC 2019 Trust, 856,044 shares via the JEC 2019 Trust, and 1,201,108 shares via the Chang 2006 Family Trust.
Sentiment
Score: 5
Explanation: The document is a standard SEC Form 4 filing, indicating a routine transaction. The sale was to cover tax obligations, which is a neutral event.
Industry Context
Sales by company insiders are a common occurrence and are often related to compensation or personal financial planning. It is important to consider the context of the sale, such as the reason for the sale and the amount of stock sold, in relation to the insider's total holdings.
Stakeholder Impact
- The sale of shares by the CEO could have a minor negative impact on shareholder sentiment, but the reason for the sale (tax obligations) mitigates this concern.
Key Dates
| Date | Description |
|---|---|
| October 1, 2019 | Date of the RTC 2019 Trust and JEC 2019 Trust |
| February 3, 2025 | Date of the stock sale transaction |
| February 5, 2025 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.